Strategic Equity Capital plc · LSE:SEC
Strategic Equity Capital — Q4 2018 Earnings Presentation
36 slides from Strategic Equity Capital's earnings presentation, 2019
Slide 1: Strategic Equity Capital PLC Q4 Update 2018
STRATEGIC EQUITY CAPITAL PLC Q4 Update 2018
Slide 2: Risk considerations
Risk considerations Risk Factors for Strategic Equity Capital plc (the Company”) – The general risk factors set out under the heading “D.1.Key Risks” of the Prospectus apply to the Company. In addition, potential investors should note the following factors: • There can be no guarantee that the inves
Slide 3: Notice to recipients
Notice to recipients This document is given to the recipient on condition that the recipient accepts that it is not a client of GVQ Investment Management Limited (“GVQIM”) and that hence, none of the client protections applicable to GVQIM’s clients are in fact in force or available, and GVQIM is not
Slide 4: Contents
Contents Q4 Update 2018 • Executive Summary 6 • Performance 7 • Detailed portfolio analysis 8 Outlook 16 Conclusion 22 Appendix 24 4
Slide 5: Q4 Update 2018
Q4 UPDATE 2018
Slide 6: Executive summary
Executive summary • Difficult quarter for global financial markets; net assets per share decreased by 10.7%. The FTSE Small Cap ex IT index (the “index”¹) decreased by 12.1% and the FTSE AIM All Share index¹ decreased by 21.5% • A confluence of global macro-economic concerns, alongside a lack of pro
Slide 7: Fund performance
Fund performance SEC NAV performance against comparator index 1 Total return % Annualised 20 14.6 15 13.4 10 8.0 3.6 3.9 4.3 5 1.3 0 -5 -3.1 -10 -10.7 -12.1 -15 -14.1 -13.8 -20 3 months 1 year 7 Feb 2017* 3 years 5 years 7 years SEC NAV Total Return FTSE Small Cap x IT Total Return Average 6.8% 7.5%
Slide 8: Q4 Attribution analysis
Q4 Attribution analysis Positive attribution (top five) bps GVQIM Comment Full year results with encouraging customer wins and high (86%) level of recurring revenue. Approach for Proactis 64 European peer Basware at a premium valuation to Proactis No significant news. Board changes with Head of Clin
Slide 9: Significant quarterly news items
Significant quarterly news items Company Recent News Comment Proactis In line full year results, 86% of annualised The approach for Basware is a further example of consolidation in the revenue is recurring e-procurement industry European peer Basware receives ‘conditional The rumoured valuation is a
Slide 10: Changes to top holdings
Changes to top 10 holdings Top 10 Q3 2018 Top 10 Q4 2018 Company % of portfolio Company % of portfolio Equiniti Group 12.1 Equiniti Group 12.1 Tribal Group 8.4 IFG Group 8.8 4imprint Group 8.1 Tribal Group 8.2 IFG Group 8.1 4imprint Group 8.0 Tyman Group 6.9 Wilmington 7.1 EMIS Group 6.7 Proactis 5.
Slide 11: Portfolio company progress and valuations provide confidence
Portfolio company progress and valuations provide confidence 50.0 45.0 +7.8% 40.0 35.0 +1.9% 30.0 P/E Ratio (NTM) +5.7% 25.0 +11.5% +7.2% +6.0% +8.1% +4.3% 20.0 -17.4% +7.4% 18.2x 18.3x 16.2x 15.0 13.2x 13.6x 11.9x 10.9x 11.2x 10.0 9.6x 7.4x 5.0 0.0 Equiniti IFG Group Tribal 4imprint Wilmington Proa
Slide 12: Top holdings
Top 10 holdings1 GVQIM GVQIM Net debt/ Company Sector Funds % of CF yield2 Investment thesis EBITDA NTM3 company NTM3 Growth through demonstrable cross-sell and margin Equiniti Group Support Services >5% 10.4% 2.2x improvement through automation and offshoring and integration of WFSS acquisition; de
Slide 13: International exposure of the portfolio
International exposure of the portfolio End market sales Portfolio Companies 4 5 3 1 UK 58% Equiniti, IFG Group, Tribal, EMIS, Medica, Harworth 2 North America 24% 4imprint, Tyman, Clinigen, Proactis 1 3 Europe 9% Clinigen, Proactis, Ergomed 2 4 Asia 5% Alliance Pharma, Oxford Metrics, Tribal 5 RoW
Slide 14: Highly concentrated and unconstrained portfolio
Highly concentrated and unconstrained portfolio Sector exposure by value Value by market cap band 10 1 Technology – software & services 22.2% 1 2 1 <£50m 0.0% 9 8 8 7 7 1 2 Support services 20.1% 2 £50m - £100m 6.1% 6 3 Healthcare 17.7% 3 £100m - £200m 41.0% 4 Financials 13.6% 4 £200m - £300m 1.9% 5
Slide 15: Portfolio valuation
Portfolio valuation1 SEC SEC FTSE UK Small Cap ex weighted average median investment trusts Number of securities 16 16 159 Market cap (£m) 366 156 318 Consensus EV/EBITDA FY1 9.5x 8.1x 6.2x Consensus price earnings FY1 11.4x 11.9x 9.4x Consensus FY1 earnings growth 12.5% 12.9% 2.4% Consensus dividen
Slide 16: Outlook
OUTLOOK
Slide 17: Extreme bearishness around UK equities
Extreme bearishness around UK equities Price and trailing DPS of UK MSCI index over time 220 200 180 160 140 120 100 80 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 Price Trailing DPS Highly negative view of UK equities reflected in >£12bn of net outflows from
Slide 18: Bear market checklist
Bear market checklist Start of Proper Bear Markets Mar-00 Oct-07 Now Global Equity Valuations Trailing PE 33 17 17 Fwd PE 24 14 14 DY 1.3 2.1 2.6 CAPE 48 30 23 Global Equity Risk Premium 1.0% 3.3% 3.3% US Yield Curve (10Y minus 2Y) -0.5 0.0 0.2 Sentiment Global Analyst Bullishness (std dev) 1.7 1.0
Slide 19: Market outlook and portfolio position
Market outlook and portfolio position Debt/monetary Macro Valuations M&A tightening Market Significant uncertainty remains in Number of UK inbound M&A Pockets of small cap are trading at the UK and global geopolitical transactions increased from 106 in peak multiples often at a premium Increasing in
Slide 20: Global private equity dry powder levels at record highs
Global private equity dry powder levels at record highs Private Equity Dry Powder by Fund Type, 2009 - 2018 Worldwide M&A volumes in H1, 1998 - 2018 $2.5trn $2.0trn $1.5trn $1.0trn $0.5trn $0.0trn 1998 2003 2008 2013 2018 Over $10bn Between $5bn and $10bn Less than $5bn HY bond yields over time (Blo
Slide 21: Earnings growth, cashflow and M&A to drive returns
Earnings growth, cashflow and M&A to drive returns SEC portfolio • Double digit aggregate earnings • Private Equity ‘dry powder’ at record growth for the portfolio levels. Any resolution to UK uncertainty could see acquirers • Portfolio growth exceeds the market, return despite portfolio’s much lowe
Slide 22: Conclusion
CONCLUSION
Slide 23: Conclusion
Conclusion • Challenging market conditions throughout the quarter as concerns regarding the health of the global economy and political uncertainty, both domestic and international, weighed heavily on markets. The FTSE Small Cap ex IT index¹ decreased by 12.1% and the FTSE AIM All Share index¹ decrea
Slide 24: Appendix
APPENDIX
Slide 25: How we identify value in potential investments
How we identify value in potential investments Main focus of most Main focus of most PUBLIC EQUITY INVESTORS PRIVATE EQUITY INVESTORS All investments undergo All investments are valued in-house, prospective using an in house cash-flow and historic leveraged buy-out model modelling Focus on recent re
Slide 26: Equiniti – a reminder of the thesis
Equiniti – a reminder of the thesis Equiniti – a market leading specialist technology and business process outsourcer • Customers include 70% of FTSE 100 • High value on the strength of cash flows companies and 70% of newly listed and structural growth drivers to both PE companies and trade: • Oppor
Slide 27: Portfolio investment themes
Portfolio investment themes DIVERSIFIED DIGITAL HEALTH REGULATION AND PENSIONS INFRASTRUCTURE PHARMA COMPLIANCE AND AND SAVINGS BUILDING Demographic and Digital maturity agenda; Increasing compliance Increase in complexity US single family population changes replacement of legacy and regulatory burd
Slide 28: MiFID II could exacerbate issues in small cap markets
MiFID II could exacerbate a number of well documented issues in small cap markets Impact of MiFID II on Small Caps Implications for SEC and Portfolio • Decreasing resources (and therefore effectiveness) on • For portfolio companies: Increasing importance of proper investor the ‘sell-side’ for small
Slide 29: Covering sell-side analysts by Market Capitalisation
Covering sell-side analysts by Market Capitalisation 600 30 24 500 25 22 400 18 20 300 15 12 200 10 7 100 5 2 0 0 £20m-£500m £500m-£1bn £1bn-£4bn £4bn-£10bn £10bn-£20bn £20bn+ Number of companies (LHS) Average number of analysts (RHS) There are a large number of smaller companies with limited sell-s
Slide 30: Asset quality
There are strict criteria for inclusion in our funds Speculative growth Fair valued GARP1 Under valued Recovery Turnaround Distress A A Investment Asset quality Asset quality focus B Avoid Avoid B C Avoid C GVQIM’s research process aims to identify high quality coveted assets with attractive cash fl
Slide 31: How we identify coveted assets
How we identify coveted assets We look for characteristics which GVQIM believes potential acquirers value highly Qualitative Quantitative • Niche market leaders • High and/or improving ROCE • Orderly end markets, with some growth • Strong cash conversion • Sustainable business model/franchise/unique
Slide 32: Our Black List screens out companies with fundamental business risks
Our Black List screens out companies with fundamental business risks Operational • Excessive reliance on a single product, customer, supplier or distributor • The primary driver of profitability cannot be influenced by management (e.g. resources) • Inherently low margins • Structurally declining mar
Slide 33: Research Committee ensures consistency of approach
Research Committee ensures consistency of approach Preliminary Investment Final Investment Monitoring Idea generation Investment Memorandum Recommendation & review Recommendation Materials • Watch list • Company description • Company meeting • Counterparty analysis • Progress against • M&A transacti
Slide 34: Long term track record
Long term track record Cumulative rebased total returns 300 280 CAGR¹ 260 SEC NAV 18.4% 240 220 200 180 160 FTSE Small Cap ex IT 12.2% 140 120 100 80 60 40 Jun 09 Jun 10 Jun 11 Jun 12 Jun 13 Jun 14 Jun 15 Jun 16 Jun 17 Jun 18 Strong cumulative performance since process improvements in June 2009. No
Slide 35: Performance
Performance Calendar Year annual performance 2018 2017 2016 2015 2014 2013 2012 Share Price Total Return -17.6% 20.2% -9.0% 14.2% 32.7% 61.5% 25.6% NAV Total Return -14.1% 21.7% 6.3% 12.1% 18.1% 46.1% 21.3% FTSE Small Cap ex Investment Trusts Total Return -13.8% 15.6% 12.5% 13.0% -2.7% 43.9% 36.3% E
Slide 36: Contact details
Contact details For further information regarding the SEC please contact the GVQ Investment Management marketing team below, or visit the Company’s website: www.strategicequitycapital.com For general enquiries, please contact: GVQ Investment Management Limited 16 Berkeley Street, London, W1J 8DZ Tel
Strategic Equity Capital — Q4 2018 Earnings Presentation on 6ix